H8H-MC-LAIJ - ClinicalTrials.gov - NCT03670810
H8H-MC-LAIJ - ClinicalTrials.gov - NCT03670810
Key Requirements
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participant must have migraine with or without aura and willing to complete an eDiary
Participant must have history of disabling migraine for at least 1 year, with migraine onset before the age of 50 years
Participant must have history of 3 to 8 migraine attacks per month (<15 headache days per month) during the past 3 months
Participants must NOT
Participant must not have history of dizziness
Participant must not have increased risk of having seizures
Participant must not have diabetes that has caused other serious health problems
Participant must not have history, within past 12 months, of chronic migraine or other forms of chronic headache disorder
Participant must not have recently started taking a new migraine preventive medication or have started taking a different dose of a preventive migraine medication
Participant must not have certain serious infections or medical conditions, including history of drug or alcohol dependence in past year
Participant must not be pregnant or breastfeeding
Trial Summary
Conditions the trial is for
Migraine
What the trial is testing?
Lasmiditan, Placebo
Could I receive a Placebo?
yes
Enrollment Goal
1600
Trial Dates
June 2019 - July 2021
Trial Phase
3
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participant must have migraine with or without aura and willing to complete an eDiary
Participant must have history of disabling migraine for at least 1 year, with migraine onset before the age of 50 years
Participant must have history of 3 to 8 migraine attacks per month (<15 headache days per month) during the past 3 months
Participants must NOT
Participant must not have history of dizziness
Participant must not have increased risk of having seizures
Participant must not have diabetes that has caused other serious health problems
Participant must not have history, within past 12 months, of chronic migraine or other forms of chronic headache disorder
Participant must not have recently started taking a new migraine preventive medication or have started taking a different dose of a preventive migraine medication
Participant must not have certain serious infections or medical conditions, including history of drug or alcohol dependence in past year
Participant must not be pregnant or breastfeeding
Trial Summary
Conditions the trial is for
Migraine
What the trial is testing?
Lasmiditan, Placebo
Could I receive a Placebo?
yes
Enrollment Goal
1600
Trial Dates
June 2019 - July 2021
Trial Phase
3
Trial Locations
Hide locations not currently recruiting